SCHEMBL24570233

SCHEMBL24570233

CC1(C)c2ccccc2-c2ccc(-c3cccc(-c4cc(-c5ccc(-n6c(-c7ccccc7)nc7ccccc76)cc5)cc(-c5ccc(-n6c(-c7ccccc7)nc7ccccc76)cc5)c4)c3)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.50
ESR2 Q92731 4/20 0.50
GRIA1 P42261 1/20 0.44
CACNG8 Q8WXS5 1/20 0.44
CACNG2 Q9Y698 1/20 0.44
HDAC1 Q13547 3/20 0.41
HDAC8 Q9BY41 3/20 0.41
HDAC6 Q9UBN7 3/20 0.41
PTGS2 P35354 1/20 0.40
RECQL P46063 1/20 0.40
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
HSP90AA1 P07900 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TP53 P04637 1/20 0.36
MAPK10 P53779 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24570824 0.98 ESR1 (0.47) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL24570626 0.95 ESR1 (0.45) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12121600 0.91 ESR1 (0.54) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL18999323 0.91 ESR1 (0.54) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12121621 0.91 ESR1 (0.54) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12121605 0.90 ESR1 (0.53) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL16692151 0.90 ESR1 (0.51) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL17470486 0.90 ESR1 (0.41) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL17470524 0.90 ESR1 (0.41) ESR1ESR2GRIA1CACNG8CACNG2
SCHEMBL12114841 0.90 ESR1 (0.41) ESR1ESR2GRIA1CACNG8CACNG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Changchun Hyperions Technology Co., Ltd. (CN) 2022-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220209132-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME EML4, STOM, GJB2 ESR1 4/4885ESR2 345/4885GRIA1 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.